UniProtKB/Swiss-Prot P04792: Variant p.Gln128Arg

Heat shock protein beta-1
Gene: HSPB1
Feedback?

Variant information Variant position:

128 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glutamine (Q) to Arginine (R) at position 128 (Q128R, p.Gln128Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and polar (Q) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In HMND3; uncertain significance; no effect on dimerization; no effect on cytoplasmic location; no effect on dimerization. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs558882005 [ dbSNP | Ensembl ]

Sequence information Variant position:

128 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

205 The length of the canonical sequence.
Location on the sequence:

ELTVKTKDGVVEITGKHEER Q DEHGYISRCFTRKYTLPPGV The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         ELTVKTKDGVVEITGKHEERQDEHGYISRCFTRKYTLPPGV

                              ELTVKTKDGVVEITGKHEERQDEHGYISRRLTPKYTLPPGV

Mouse                         ELTVKTKEGVVEITGKHEERQDEHGYISRCFTRKYTLPPGV

Rat                           ELTVKTKEGVVEITGKHEERQDEHGYISRCFTRKYTLPPGV

Pig                           ELTVKTKDGVVEITGKHEERQDEHGFISRCFTRKYTLPPGV

Bovine                        ELTVKTKDGVVEITGKHEERQDEHGYISRCFTRKYTLPPGV

Chicken                       ELVVKTKDNIVEITGKHEEKQDEHGFISRCFTRKYTLPPGV

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 205	Heat shock protein beta-1
Domain	76 – 184	sHSP
Region	70 – 205	Interaction with TGFB1I1
Modified residue	123 – 123	N6-acetyllysine

Literature citations
Axonal Neuropathies due to Mutations in Small Heat Shock Proteins: Clinical, Genetic, and Functional Insights into Novel Mutations.
Echaniz-Laguna A.; Geuens T.; Petiot P.; Pereon Y.; Adriaenssens E.; Haidar M.; Capponi S.; Maisonobe T.; Fournier E.; Dubourg O.; Degos B.; Salachas F.; Lenglet T.; Eymard B.; Delmont E.; Pouget J.; Juntas Morales R.; Goizet C.; Latour P.; Timmerman V.; Stojkovic T.;
Hum. Mutat. 38:556-568(2017)
Cited for: VARIANTS HMND3 SER-7; LEU-39; ASP-53; TRP-127; ARG-128; ILE-151; 175-GLN--LYS-205 DEL; ILE-180 AND LEU-187; SUBCELLULAR LOCATION; CHARACTERIZATION OF VARIANTS HMND3 SER-7; ASP-53; ARG-128 AND LEU-187;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.